PDGFR-β As a New Therapeutic Target in T-Cell Acute Lymphoblastic Leukemia

被引:1
|
作者
De Coninck, Stien [1 ,2 ,3 ]
De Smedt, Renate [1 ,2 ,3 ]
Lintermans, Beatrice [1 ,2 ,3 ]
Goossens, Steven [3 ,4 ]
Van Vlierberghe, Pieter [1 ,2 ,3 ]
机构
[1] Univ Ghent, Ctr Med Genet, Ghent, Belgium
[2] Univ Ghent, Dept Biomol Med, Ghent, Belgium
[3] Canc Res Inst Ghent CRIG, Ghent, Belgium
[4] Univ Ghent, Dept Diagnost Sci, Ghent, Belgium
关键词
D O I
10.1182/blood-2022-168556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
603
引用
收藏
页码:11513 / 11514
页数:2
相关论文
共 50 条
  • [1] Pre-T cell receptor as a therapeutic target in T-cell acute lymphoblastic leukemia
    Fuentes, Patricia
    Peydro, Marina Garcia
    Mosquera, Marta
    Alcain, Juan
    Alarcon, Balbino
    Toribio, Maria L.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 411 - 411
  • [2] The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
    Lato, Marta Weronika
    Przysucha, Anna
    Grosman, Sylwia
    Zawitkowska, Joanna
    Lejman, Monika
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [3] CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia
    Naik, Jyoti
    Themeli, Maria
    de Jong-Korlaar, Regina
    Ruiter, Ruud W. J.
    Poddighe, Pino J.
    Yuan, Huipin
    Bruijn, Joost D. d.
    Ossenkoppele, Gert J.
    Zweegman, Sonja
    Smit, Linda
    Mutis, Tuna
    Martens, Anton C. M.
    de Donk, Niels W. C. J. van
    Groen, Richard W. J.
    [J]. HAEMATOLOGICA, 2019, 104 (03) : E100 - E103
  • [4] Notch, a unifying target in T-cell acute lymphoblastic leukemia?
    Screpanti, I
    Bellavia, D
    Campese, AF
    Frati, L
    Gulino, A
    [J]. TRENDS IN MOLECULAR MEDICINE, 2003, 9 (01) : 30 - 35
  • [5] TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia
    Bensberg, Maike
    Rundquist, Olof
    Selimovic, Aida
    Lagerwall, Cathrine
    Benson, Mikael
    Gustafsson, Mika
    Vogt, Hartmut
    Lentini, Antonio
    Nestor, Colm E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (34)
  • [6] New Approaches to T-Cell Acute Lymphoblastic Leukemia
    Teachey, David T.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 295 - 298
  • [7] Identification of EHMT2 As a New Target in T-Cell Acute Lymphoblastic Leukemia
    Kitara, Samuel
    Su, Angela
    Deluca, Claudio
    Aversa, Franco
    Knoechel, Birgit
    Jin, Jian
    Stegmaier, Kimberly
    Roti, Giovanni
    [J]. BLOOD, 2017, 130
  • [8] Identification of EHMT2 As a New Target in T-Cell Acute Lymphoblastic Leukemia
    Kitara, Samuel
    Su, Angela
    Deluca, Claudio
    Aversa, Franco
    Knoechel, Birgit
    Jin, Jian
    Stegmaier, Kimberly
    Roti, Giovanni
    [J]. BLOOD, 2017, 130
  • [9] Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia
    Cani, Alice
    Simioni, Carolina
    Martelli, Alberto M.
    Zauli, Giorgio
    Tabellini, Giovanna
    Ultimo, Simona
    McCubrey, James A.
    Capitani, Silvano
    Neri, Luca M.
    [J]. ONCOTARGET, 2015, 6 (09) : 6597 - 6610
  • [10] RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia
    Pham, Loc Thi
    Peng, Hui
    Ueno, Masaya
    Kohno, Susumu
    Kasada, Atuso
    Hosomichi, Kazuyoshi
    Sato, Takehiro
    Kurayoshi, Kenta
    Kobayashi, Masahiko
    Tadokoro, Yuko
    Kasahara, Atsuko
    Shoulkamy, Mahmoud, I
    Xiao, Bo
    Worley, Paul F.
    Takahashi, Chiaki
    Tajima, Atsushi
    Hirao, Atsushi
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 621 : 74 - 79